查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2015455

北美毒理学实验室市场：市场洞察、竞争格局和市场预测（2033 年）

North America Toxicology Laboratories Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 194 Pages | 商品交期: 2-5个工作天内

价格
简介目录

北美毒理学实验室市场正经历强劲成长，主要受对先进药物检测、法医学分析和临床诊断需求不断增长的推动。该市场在2026年的价值为2.945亿美元，预计到2033年将达到6.154亿美元，预测期内复合年增长率（CAGR）为11.10%。药物滥用案件的增加、监管合规要求的提高以及技术的进步是推动市场成长的重要因素。对检查室确诊检测的日益依赖以及北美地区药物滥用疾病负担的加重进一步加剧了市场需求。医疗保健基础设施的不断改进和精准诊断解决方案的日益普及也为行业增长提供了支持。

市场洞察－自动化毒理学检测平台和高通量筛检技术正被市场迅速采用。层析法、免疫检测和分子诊断法的整合提高了检测的准确性和效率。更严格的职场药物筛检要求和法医学调查的增加进一步推动了检测数量的成长。实验室越来越多地采用数位化报告系统、基于云端的数据管理和人工智慧分析，以缩短处理时间并提高结果准确性。多种药物滥用案件的日益复杂化也促使实验室采用先进的多组检测解决方案。

驱动因素－主要驱动因素包括药物和酒精滥用案件的增加、政府监管的日益严格以及对精准法医学调查需求的增长。临床毒理学检测的增加和医院检查室的扩建也推动了市场成长。液相层析串联质谱（LC-MS/MS）和基于聚合酶炼式反应（PCR）的检测等技术进步提高了检测能力和操作效率。交通运输、医疗保健和企业部门对职场安全意识的提高以及强制性药物检测政策的实施进一步加速了市场需求。公共卫生监测计画资金的增加也促进了市场扩张。

商机——检查室自动化、復健中心扩建以及毒理学检测服务外包领域蕴藏着巨大的商机。对快速照护现场（POC​​）毒理学筛检日益增长的需求正在创造新的收入来源。私人诊断公司正投资先进设备和试剂创新，以提高检测的灵敏度和速度。法医学在刑事司法系统中的广泛应用也开闢了新的成长途径。随着个人化医疗的普及，对高级毒理学分析的需求预计将进一步增长。

区域分析－美国凭藉其先进的医疗保健基础设施、庞大的检测量和健全的法规结构，在北美毒理学检测市场占据主导地位。加拿大也呈现稳定成长，这得益于人们对药物滥用监测意识的提高以及政府主导的医疗保健倡议。诊断检测网络的扩展和对公共卫生计画投入的增加，持续推动北美各地市场的成长。

主要企业：

  • Thermo Fisher Scientific, Inc.
  • Bio Rad Laboratories Inc.
  • Neogen Corporation
  • Danaher Corporation
  • Agilent
  • Redwood Toxicology Laboratory
  • Abbott (Alere, Inc.)

分割：

药物分类：

  • 酒精
  • 安非他命
  • 巴比妥类药物
  • 苯二氮平类药物
  • 非法药物
  • 阿片类药物/鸦片类镇痛药
  • 三环抗忧郁药物
  • Z型药物
  • 其他的

产品类型：

  • 试剂组
  • ELISA
  • PCR
  • 酵素增殖免疫检测（EMIT）
  • 免疫检测（RIA）
  • 装置
  • 免疫化学分析仪
  • PCR装置
  • 气相层析法/质谱联用（GC/MS）
  • 高效液相层析（HPLC）

检体：

  • 尿
  • 血
  • 头髮
  • 口腔液

最终用户：

  • 医院
  • 诊所
  • 诊断检查室
  • 刑事鑑定实验室
  • 復健中心

按地区划分：

  • 北美洲
  • 我们
  • 加拿大

目录

第一章执行摘要

第二章 市场概览

  • 市场定义与细分
  • 市场动态
    • 促进因素
    • 抑制因子
    • 市场机会
  • 价值链分析
  • 新冠疫情影响分析
  • 波特五力分析
  • 俄乌衝突的影响
  • PESTLE分析
  • 监管分析
  • 价格趋势分析
    • 当前价格及未来预测（2025-2033）
    • 价格影响因素

第三章：2020-2033年北美毒理学实验室市场展望

  • 北美毒理学实验室市场展望，按药物分类，价值（百万美元），2020-2033年
    • 酒精
    • 安非他命
    • 巴比妥类药物
    • 巴比妥类药物
    • 苯二氮平类药物
    • 非法药物
    • 阿片类药物
    • 三环抗忧郁药物
    • Z 药品
    • 其他的
  • 北美毒理学实验室市场展望，按产品类型划分，价值（百万美元），2020-2033年
    • 试剂组
    • 装置
  • 北美毒理学实验室市场展望，按检体类型划分，价值（百万美元），2020-2033年
    • 尿
    • 血
    • 头髮
    • 口腔液
  • 北美毒理学实验室市场展望（按最终用户划分，价值（百万美元）），2020-2033年
    • 医院
    • 诊所
    • 诊断检查室
    • 法医学研究所
    • 復健中心
  • 北美毒理学实验室市场展望（按地区划分，价值（百万美元）），2020-2033年
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第四章：2020-2033年北美毒理学实验室市场展望

第五章：2020-2033年欧洲毒理学实验室市场展望

第六章：2020-2033年亚太毒理学实验室市场展望

第七章：2020-2033年拉丁美洲毒理学实验室市场展望

第八章：2020-2033年中东和非洲毒理学实验室市场展望

第九章 竞争情势

  • 公司与细分市场热图
  • 2025年各公司市占率分析
  • 竞争对手仪錶板
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Bio Rad Laboratories Inc.
    • Neogen Corporation
    • Danaher Corporation
    • Agilent
    • Redwood Toxicology Laboratory
    • Abbott (Alere, Inc.)

第十章附录

简介目录

The North America Toxicology Laboratories Market is witnessing robust expansion driven by increasing demand for advanced drug testing, forensic analysis, and clinical diagnostics. The market is valued at 294.5 mn in 2026 and is projected to reach 615.4 mn in 2033, registering a CAGR of 11.10% during the forecast period. Rising substance abuse cases, regulatory compliance requirements, and technological advancements are significantly contributing to market growth. Increasing reliance on laboratory-based confirmation testing and the growing burden of substance misuse disorders across North America are further strengthening market demand. Expansion of healthcare infrastructure and rising adoption of precision diagnostic solutions are also supporting industry growth.

Market Insights: The market is experiencing strong adoption of automated toxicology testing platforms and high-throughput screening technologies. Integration of chromatography, immunoassays, and molecular diagnostics is enhancing accuracy and efficiency. Increasing workplace drug screening requirements and forensic investigations are further driving testing volumes. Laboratories are increasingly adopting digital reporting systems, cloud-based data management, and AI-assisted analytics to improve turnaround time and result accuracy. Growing complexity of poly-drug abuse cases is also pushing laboratories to adopt advanced multi-panel testing solutions.

Drivers: Key drivers include rising drug and alcohol abuse cases, stringent government regulations, and increasing need for accurate forensic investigations. Growth in clinical toxicology testing and expansion of hospital-based laboratories are also supporting market growth. Technological advancements such as LC-MS/MS and PCR-based testing are improving detection capabilities and operational efficiency. Rising awareness regarding workplace safety and mandatory drug testing policies in transportation, healthcare, and corporate sectors are further accelerating demand. Increased funding for public health surveillance programs is also contributing to market expansion.

Business Opportunity: Significant opportunities exist in laboratory automation, expansion of rehabilitation centers, and outsourcing of toxicology testing services. Growing demand for rapid, point-of-care toxicology screening is creating new revenue streams. Private diagnostic companies are investing in advanced instrumentation and reagent innovation to improve testing sensitivity and speed. Expansion of forensic science applications in criminal justice systems is also opening new growth avenues. Increasing adoption of personalized medicine is expected to further enhance demand for advanced toxicology profiling.

Region Analysis: The United States dominates the North America Toxicology Laboratories Market due to advanced healthcare infrastructure, high testing volumes, and strong regulatory frameworks. Canada is also witnessing steady growth driven by increasing awareness of substance abuse monitoring and government-led healthcare initiatives. Expansion of diagnostic laboratory networks and rising investment in public health programs continue to support regional growth across North America.

Key Players:

  • Thermo Fisher Scientific, Inc.
  • Bio Rad Laboratories Inc.
  • Neogen Corporation
  • Danaher Corporation
  • Agilent
  • Redwood Toxicology Laboratory
  • Abbott (Alere, Inc.)

Segmentation:

Drug Class:

  • Alcohol
  • Amphetamines
  • Barbiturates
  • Benzodiazepines
  • Illicit Drugs
  • Opiates/Opioids
  • Tricyclic's Antidepressants
  • Z Drugs
  • Misc

Product Type:

  • Reagent Kits
  • ELISA
  • PCR
  • Enzyme Multiplied Immunoassay Technique (EMIT)
  • Radio Immuno-sorbent Assay (RIA)
  • Instruments
  • Immunochemistry Analyzers
  • PCR Machine
  • Gas Chromatography/Mass Spectrometry (GS/MS)
  • High Performance Liquid Chromatography (HPLC)

Sample:

  • Urine
  • Blood
  • Hair
  • Oral Fluid

End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Rehabilitation Centers

By Geographic Coverage:

  • North America
  • U.S.
  • Canada

Table of Contents

1. Executive Summary

  • 1.1. Global North America Toxicology Laboratories Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global North America Toxicology Laboratories Market Outlook, 2020-2033

  • 3.1. Global North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 3.1.1. Alcohol
    • 3.1.2. Amphetamines
    • 3.1.3. Barbiturates
    • 3.1.4. Barbiturates
    • 3.1.5. Benzodiazepines
    • 3.1.6. Illicit Drugs
    • 3.1.7. Opiates/Opioids
    • 3.1.8. Tricyclic's Antidepressants
    • 3.1.9. Z Drugs
    • 3.1.10. Misc
  • 3.2. Global North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 3.2.1. Reagent Kits
      • 3.2.1.1. ELISA
      • 3.2.1.2. PCR
      • 3.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 3.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 3.2.2. Instruments
      • 3.2.2.1. Immunochemistry Analyzers
      • 3.2.2.2. PCR Machine
      • 3.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 3.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 3.3. Global North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 3.3.1. Urine
    • 3.3.2. Blood
    • 3.3.3. Hair
    • 3.3.4. Oral Fluid
  • 3.4. Global North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 3.4.1. Hospitals
    • 3.4.2. Clinics
    • 3.4.3. Diagnostic Laboratories
    • 3.4.4. Forensic Laboratories
    • 3.4.5. Rehabilitation Centers
  • 3.5. Global North America Toxicology Laboratories Market Outlook, by Region, Value (US$ Mn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America North America Toxicology Laboratories Market Outlook, 2020-2033

  • 4.1. North America North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 4.1.1. Alcohol
    • 4.1.2. Amphetamines
    • 4.1.3. Barbiturates
    • 4.1.4. Barbiturates
    • 4.1.5. Benzodiazepines
    • 4.1.6. Illicit Drugs
    • 4.1.7. Opiates/Opioids
    • 4.1.8. Tricyclic's Antidepressants
    • 4.1.9. Z Drugs
    • 4.1.10. Misc
  • 4.2. North America North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 4.2.1. Reagent Kits
      • 4.2.1.1. ELISA
      • 4.2.1.2. PCR
      • 4.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 4.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 4.2.2. Instruments
      • 4.2.2.1. Immunochemistry Analyzers
      • 4.2.2.2. PCR Machine
      • 4.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 4.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 4.3. North America North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 4.3.1. Urine
    • 4.3.2. Blood
    • 4.3.3. Hair
    • 4.3.4. Oral Fluid
  • 4.4. North America North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 4.4.1. Hospitals
    • 4.4.2. Clinics
    • 4.4.3. Diagnostic Laboratories
    • 4.4.4. Forensic Laboratories
    • 4.4.5. Rehabilitation Centers
  • 4.5. North America North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 4.5.1. U.S. North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 4.5.2. U.S. North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 4.5.3. U.S. North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 4.5.4. U.S. North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 4.5.5. Canada North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 4.5.6. Canada North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 4.5.7. Canada North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 4.5.8. Canada North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe North America Toxicology Laboratories Market Outlook, 2020-2033

  • 5.1. Europe North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 5.1.1. Alcohol
    • 5.1.2. Amphetamines
    • 5.1.3. Barbiturates
    • 5.1.4. Barbiturates
    • 5.1.5. Benzodiazepines
    • 5.1.6. Illicit Drugs
    • 5.1.7. Opiates/Opioids
    • 5.1.8. Tricyclic's Antidepressants
    • 5.1.9. Z Drugs
    • 5.1.10. Misc
  • 5.2. Europe North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 5.2.1. Reagent Kits
      • 5.2.1.1. ELISA
      • 5.2.1.2. PCR
      • 5.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 5.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 5.2.2. Instruments
      • 5.2.2.1. Immunochemistry Analyzers
      • 5.2.2.2. PCR Machine
      • 5.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 5.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 5.3. Europe North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 5.3.1. Urine
    • 5.3.2. Blood
    • 5.3.3. Hair
    • 5.3.4. Oral Fluid
  • 5.4. Europe North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 5.4.1. Hospitals
    • 5.4.2. Clinics
    • 5.4.3. Diagnostic Laboratories
    • 5.4.4. Forensic Laboratories
    • 5.4.5. Rehabilitation Centers
  • 5.5. Europe North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 5.5.1. Germany North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.2. Germany North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.3. Germany North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.4. Germany North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.5. Italy North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.6. Italy North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.7. Italy North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.8. Italy North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.9. France North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.10. France North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.11. France North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.12. France North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.13. U.K. North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.14. U.K. North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.15. U.K. North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.16. U.K. North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.17. Spain North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.18. Spain North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.19. Spain North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.20. Spain North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.21. Russia North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.22. Russia North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.23. Russia North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.24. Russia North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.25. Rest of Europe North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.26. Rest of Europe North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.27. Rest of Europe North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.28. Rest of Europe North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific North America Toxicology Laboratories Market Outlook, 2020-2033

  • 6.1. Asia Pacific North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 6.1.1. Alcohol
    • 6.1.2. Amphetamines
    • 6.1.3. Barbiturates
    • 6.1.4. Barbiturates
    • 6.1.5. Benzodiazepines
    • 6.1.6. Illicit Drugs
    • 6.1.7. Opiates/Opioids
    • 6.1.8. Tricyclic's Antidepressants
    • 6.1.9. Z Drugs
    • 6.1.10. Misc
  • 6.2. Asia Pacific North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 6.2.1. Reagent Kits
      • 6.2.1.1. ELISA
      • 6.2.1.2. PCR
      • 6.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 6.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 6.2.2. Instruments
      • 6.2.2.1. Immunochemistry Analyzers
      • 6.2.2.2. PCR Machine
      • 6.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 6.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 6.3. Asia Pacific North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 6.3.1. Urine
    • 6.3.2. Blood
    • 6.3.3. Hair
    • 6.3.4. Oral Fluid
  • 6.4. Asia Pacific North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 6.4.1. Hospitals
    • 6.4.2. Clinics
    • 6.4.3. Diagnostic Laboratories
    • 6.4.4. Forensic Laboratories
    • 6.4.5. Rehabilitation Centers
  • 6.5. Asia Pacific North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 6.5.1. China North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.2. China North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.3. China North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.4. China North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.5. Japan North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.6. Japan North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.7. Japan North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.8. Japan North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.9. South Korea North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.10. South Korea North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.11. South Korea North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.12. South Korea North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.13. India North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.14. India North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.15. India North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.16. India North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.17. Southeast Asia North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.18. Southeast Asia North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.19. Southeast Asia North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.20. Southeast Asia North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.21. Rest of SAO North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.22. Rest of SAO North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.23. Rest of SAO North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.24. Rest of SAO North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America North America Toxicology Laboratories Market Outlook, 2020-2033

  • 7.1. Latin America North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 7.1.1. Alcohol
    • 7.1.2. Amphetamines
    • 7.1.3. Barbiturates
    • 7.1.4. Barbiturates
    • 7.1.5. Benzodiazepines
    • 7.1.6. Illicit Drugs
    • 7.1.7. Opiates/Opioids
    • 7.1.8. Tricyclic's Antidepressants
    • 7.1.9. Z Drugs
    • 7.1.10. Misc
  • 7.2. Latin America North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 7.2.1. Reagent Kits
      • 7.2.1.1. ELISA
      • 7.2.1.2. PCR
      • 7.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 7.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 7.2.2. Instruments
      • 7.2.2.1. Immunochemistry Analyzers
      • 7.2.2.2. PCR Machine
      • 7.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 7.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 7.3. Latin America North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 7.3.1. Urine
    • 7.3.2. Blood
    • 7.3.3. Hair
    • 7.3.4. Oral Fluid
  • 7.4. Latin America North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Diagnostic Laboratories
    • 7.4.4. Forensic Laboratories
    • 7.4.5. Rehabilitation Centers
  • 7.5. Latin America North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 7.5.1. Brazil North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 7.5.2. Brazil North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 7.5.3. Brazil North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 7.5.4. Brazil North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 7.5.5. Mexico North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 7.5.6. Mexico North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 7.5.7. Mexico North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 7.5.8. Mexico North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 7.5.9. Argentina North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 7.5.10. Argentina North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 7.5.11. Argentina North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 7.5.12. Argentina North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 7.5.13. Rest of LATAM North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 7.5.14. Rest of LATAM North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 7.5.15. Rest of LATAM North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 7.5.16. Rest of LATAM North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa North America Toxicology Laboratories Market Outlook, 2020-2033

  • 8.1. Middle East & Africa North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 8.1.1. Alcohol
    • 8.1.2. Amphetamines
    • 8.1.3. Barbiturates
    • 8.1.4. Barbiturates
    • 8.1.5. Benzodiazepines
    • 8.1.6. Illicit Drugs
    • 8.1.7. Opiates/Opioids
    • 8.1.8. Tricyclic's Antidepressants
    • 8.1.9. Z Drugs
    • 8.1.10. Misc
  • 8.2. Middle East & Africa North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 8.2.1. Reagent Kits
      • 8.2.1.1. ELISA
      • 8.2.1.2. PCR
      • 8.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 8.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 8.2.2. Instruments
      • 8.2.2.1. Immunochemistry Analyzers
      • 8.2.2.2. PCR Machine
      • 8.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 8.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 8.3. Middle East & Africa North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 8.3.1. Urine
    • 8.3.2. Blood
    • 8.3.3. Hair
    • 8.3.4. Oral Fluid
  • 8.4. Middle East & Africa North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 8.4.1. Hospitals
    • 8.4.2. Clinics
    • 8.4.3. Diagnostic Laboratories
    • 8.4.4. Forensic Laboratories
    • 8.4.5. Rehabilitation Centers
  • 8.5. Middle East & Africa North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 8.5.1. GCC North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.2. GCC North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.3. GCC North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.4. GCC North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 8.5.5. South Africa North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.6. South Africa North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.7. South Africa North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.8. South Africa North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 8.5.9. Egypt North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.10. Egypt North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.11. Egypt North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.12. Egypt North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 8.5.13. Nigeria North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.14. Nigeria North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.15. Nigeria North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.16. Nigeria North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 8.5.17. Rest of Middle East North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.18. Rest of Middle East North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.19. Rest of Middle East North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.20. Rest of Middle East North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Bio Rad Laboratories Inc.
    • 9.4.3. Neogen Corporation
    • 9.4.4. Danaher Corporation
    • 9.4.5. Agilent
    • 9.4.6. Redwood Toxicology Laboratory
    • 9.4.7. Abbott (Alere, Inc.)

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations